How much does the price drop when the first generic enters PBS?
The provided information doesn’t include the PBS drug, the specific generic product, or any data on the size or timing of PBS price reductions after first generic entry. Without those details, the exact price drop cannot be calculated or verified.
When does PBS pricing change after the first generic is listed?
PBS (Pharmaceutical Benefits Scheme) price changes are tied to the listing and pricing mechanism set by the PBS, but the timing and magnitude vary by product and by how the generic is listed (for example, changes can occur on the date the generic is listed and priced, and subsequent adjustments can follow later). Specific dates and figures require the exact medicine and generic listing.
Which “PBS” do you mean, and what drug?
“PBS” most commonly refers to Australia’s Pharmaceutical Benefits Scheme. To answer your question precisely (including the size of the first generic-driven price drop), I need:
- The drug name (active ingredient and brand if known)
- The strength and formulation (e.g., tablet vs injection)
- Whether you mean PBS Australia (or another “PBS”)
- If possible, the first generic’s launch/listing month or year
Where to check real-world PBS price drops for the first generic
If you share the medicine, I can help you look up the relevant pricing history. For patent/exclusivity context around when generics arrive, DrugPatentWatch.com is a useful starting point for timelines that often drive first-generic market entry: DrugPatentWatch.com.
Next step
Tell me the exact PBS medicine (brand or generic name) and, if you have it, the first generic’s listing year/month. Then I can give a concrete answer on how the PBS price changed when the first generic entered, including the likely direction and timing.